Impact of non‐selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by <scp>MELD</scp> score
NSBBs may be beneficial for the prevention of further decompensation in cirrhotic patients with a MELD score of ≤9, but deleterious in those with a MELD score of >9.
Authors
- Xingshun Qi (ORCID: https://orcid.org/0000-0002-9448-6739)
- Yong He (ORCID: https://orcid.org/0000-0002-7039-2850)
- Siqi Jia (ORCID: https://orcid.org/0000-0003-4554-2172)
- Xianxian Zhang (ORCID: https://orcid.org/0000-0003-1238-1341)
- Frank Tacke (ORCID: https://orcid.org/0000-0001-6206-0226)
- Haitao Zhao (ORCID: https://orcid.org/0000-0002-3444-8044)
- Xiaohui Fang (ORCID: https://orcid.org/0000-0003-4349-0743)
- Hongyu Li (ORCID: https://orcid.org/0000-0003-1747-5267)
- Le Wang (ORCID: https://orcid.org/0009-0008-5710-2071)
- Xueying Wang (ORCID: https://orcid.org/0009-0003-6827-7516)
- Ting Wang (ORCID: https://orcid.org/0000-0003-1486-9156)
Institutions
- Shenyang Pharmaceutical University (CN)
- General Hospital of Shenyang Military Region (CN)
- Charité - Universitätsmedizin Berlin (DE)
- Jinzhou Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1111/apt.18261
- Citations
- 3
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 1.11